Finding a four-leaf clover-identifying long-term survivors in IDH-wildtype glioblastoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited.Cancer reports (Hoboken, N.J.) · 2023
   Review
2. PiDeeL: metabolic pathway-informed deep learning model for survival analysis and pathological classification of gliomas.Bioinformatics (Oxford, England) · 2023
   Article
3. Long non-coding RNA LINC00470 in serum derived exosome: a critical regulator for proliferation and autophagy in glioma cells.Cancer cell international · 2021
   Article
4. Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma.Frontiers in oncology · 2021
   Article
5. Multiple extracranial metastases from glioblastoma multiforme: a case report and literature review.The Journal of international medical research · 2020
   Review

Corrections and comments

• Comment on
  Molecular profiling of long-term IDH-wildtype glioblastoma survivors.2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as